A Case-Control Study of Male Breast Cancer

Cancer Research

Volumn 48, Issue 5, 1988, Pages 1326-1330

  Casagrande, John T ^a   Hanisch, Rosemarie ^a   Pike, Malcolm C ^b   Ross, Ronald K ^b   Brown, James B ^c   Henderson, Brian E ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASE CONTROL STUDY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE BREAST CANCER; RISK FACTOR;

ADULT; AGED; ALCOHOL DRINKING; BODY WEIGHT; BREAST NEOPLASMS; ESTROGENS; HUMAN; MALE; MARRIAGE; MIDDLE AGE; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; SUPPORT, U.S. GOV'T, P.H.S.; TESTOSTERONE;

EID: 0023847833     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Waterhouse, J., Muir, C., Shanmugaratnam, K., and Powell, J. (eds.). Cancer Incidence in Five Continents. IARC Scientific Publication No. 42. International Agency for Research on Cancer. Lyon, France, 1982.
2. Schottenfeld, D., Lilienfeld, A. M., and Diamond, H. Some observations on the epidemiology of breast cancer among males. Am. J. Pub. Hlth., 53: 890-897, 1963.
3. Keller, A. Z. Demographic, clinical and survivor ship characteristics of males with primary cancer of the breast. Am. J. Epidemiol., 85: 183-199, 1967.
4. Mabuchi, K., Bross, D. S., and Kessler, I. I. Risk factors for male breast cancer. J. Natl. Cancer Inst., 74: 371-375, 1985.
5. Abramson, W., and Warshawsky, H. Cancer of the breast in the male, secondary to estrogenic administration: Report of a case. J. Urol., 59: 76-82, 1948.
6. McClure, J. A., and Higgins, C. C. Bilateral carcinoma of male breast after estrogen therapy. JAMA, 146: 7-9 and 1608, 1951.
7. Symmers, W. S. C. Carcinoma of the breast in trans-sexual individuals after surgical and hormonal interference with primary and secondary sex characteristics. Br. Med. J., 2: 83-85, 1968.
8. Hisserich, J. C., Martin, S. P., and Henderson, B. E. An area wide cancer reporting network. Pub. Hlth. Rep., 90: 15-17, 1975.
9. Ehara, Y., Siler, T., Van Den Berg, G., et al. Circulating prolactin levels during the menstrual cycle: Episodic release and diurnal variation. Am. J. Obstet. Gynecol., 117: 962-970, 1973.
10. Furuyaina, S., Mayes, D. M., and Nugent, C. A. A radioimmunoassay for plasma testosterone. Steroids, 16: 415-428, 1970.
11. Wu, C., and Lundy, E. Radioimmunoassay of plasma estrogens. Steroids, 18: 91-111, 1971.
12. Nankin, H. R., Pinto, R., Fan, D. F., et al. Daytime titers of testosterone, LH, estrone, estradiol and testosterone-binding protein: Acute effects of LH and LH-releasing hormone in men. J. Clin. Endocrinol. Metab., 41: 271-281, 1975.
13. Pardridge, W. M., and Mietus, L. J. Transport of steroid hormones through the rat blood-brain barrier. J. Clin. Invest., 64: 145-154, 1979.
14. Brown, J. B., Macnaughtan, C., Smith, M. A., et al. Further observations on the Kober colour and Ittrich fluorescencere action in the measurement of oestriol, oestrone, and oestradiol. J. Endocrinol., 40: 175-188, 1968.
15. Breslow, N. E., and Day, N. E. Statistical methods in cancer research. Vol I. The analysis of case-control studies. International Agency for Research on Cancer. Lyon: France, 1980.
16. Kleinbaum, D. G., and Kupper, L. L. Applied regression analyses and other multivariate methods, pp. 209-226. North Scituate, MA: Duxbury Press, 1987.
17. Scheike, O., Visfeldt, J., and Peterson, B. Male breast cancer. 3. Breast carcinoma in association with the Klinefelter syndrome. Acta Path. Micro biol. Scand.A., 81: 352-358, 1973.
18. Hollingshead, A. B., and Redlick, F. C. Social class and mental illness. New York: Wiley, 1958.
19. Dubois, D., and Dubois, E. F. A formula to estimate the approximate surface area if height and weight be known. Arch. Int. Med., 17: 863-871, 1916.
20. Scheike, O., and Visfeldt, J. Male breast cancer. 4. Gynecomastia in patients with breast cancer. Acta Path. Micro biol. Scand. A., 81: 359-365, 1973.
21. Meyskens, F. L., Tormey, D. C., and Neifeld, J. P. Male breast cancer a review. Cancer Treat. Rev., 3: 83-93, 1976.
22. Jackson, A. W., Muldal, S., Ockey, C. H., et al. Carcinoma of male breast in association with the Klinefelter syndrome. Br. Med. J., i: 223-225, 1965.
23. Nadel, M., and Koss, L. G. Klinefelter's syndrome and male breast cancer. Lancet, ii: 366, 1967.
24. Harnden, D. G., Maclean, N., and Langlands, A. O. Carcinoma of the breast and Klinefelter's syndrome. J. Med. Genetics, 8: 460-461, 1971.
25. Giorgi, E. P., and Sommerville, I. F. Hormone assays in Klinefelter's syndrome. J. Clin. Endocrinol. Metab., 23: 197-202, 1963.
26. Gabrilove, E. P., Nicolis, G. L., and Hausknecht, R. U. Urinary testosterone, oestrogen production rate and urinary oestrogen in chromatin positive Klinefelter's syndrome. Acta Endocrinol, 63: 499-504, 1970.
27. Siiteri, P. K., and MacDonald, P. C. Role of extra glandular estrogen in human endocrinology. In R. O. Greep and E. B. Astwood (eds.), Handbook of Physiology, Vol 2. Washington, DC: American Physiological Society, 1973.
28. Large, D.M., and Anderson, D. C. Twenty four hour profiles of circulating androgens and oestrogens in male puberty with and without gynecomastia. Clin. Endocrinol., 11: 505-521, 1979.
29. McFadyen, I. J., Bolton, A. E., Cameron, E. H. D., et al. Gonadal-pituitary hormone levels in gynecomastia. Clin. Endocrinol., 13: 77-86, 1980.
30. Court-Brown, W. M. Sexchromosome aneuploidy in man and its frequency with special reference to mental subnormality and criminal behavior. Int. Rev. Exp. Path., 7: 31-97, 1969.
31. England, P. C., Skinner, L. G., Cottrell, K. M., et al. Serum oestradiol 17beta in women with benign and malignant breast disease. Br. J. Cancer, 30: 571-576, 1974.
32. Cole, P., Cramer, D., Yen, S., et al., Estrogen profiles of premenopausal women with breast cancer. Cancer Res., 38: 745-748, 1978.
33. Brown, J. B. Urinary oestrogen excretion in the study of mammary cancer. In: Curie, A. R. (ed.), Endocrine Aspects of Breast Cancer, Edinburgh: E and S Livingstone, 1958.
34. Hill, P., Wynder, E. L., Kumar, H., et al. Prolactin levels in populations at risk of breast cancer. Cancer Res., 36: 4102-4106, 1976.
35. Pike, M. C., Casagrande, J. T., Brown, J. B., et al. Comparison of urinary and plasma hormone levels in daughters of breast cancer patients and controls. J. Natl. Cancer Inst., 59: 1351-1355, 1977.
36. Schneider, G., Kirschner, M. A., Berkowitz, R., and Ertel, N. H. Increased estrogen production in obesemen. J. Clin. Endocrinol. Metab., 48: 633-638, 1979.
37. Kley, H. K., Edelman, P., and Kruskemper, H. L. Relationship of plasma sex hormones to different parameters of obesity in male subjects. Metabolism, 29: 1041-1045, 1980.
38. Kley, H. K., Deselaers, T., Peerenboom, H., and Kruskemper, H. L. Enhanced conversion of androstenedione to estrogens in obesemales. J. Clin. Endocrinol. Metab., 51: 1128-1132, 1980.
39. Calabresi, E., DeGiuli, G., Becciolini, A., et al. Plasma estrogens and androgens in male breast cancer. J. Steroid Biochem., 7: 605-609, 1976.
40. Ribeiro, G. G., Phillips, H. V., and Skinner, L. G. Serum oestradiol-17B, testosterone, luteinizing hormone and follicle-stimulating hormone in males with breast cancer. Br. J. Cancer, 41: 474-477, 1980.
41. Dao, T. L., Morreal, C., and Nemoto, T. Urinary estrogen excretion in men with breast cancer. N. Engl. J. Med., 289: 138-140, 1973.
42. Scheike, O., Svenstrup, B., and Frandsen, V. A. Male breast cancer. 2. Metabolism of oestradiol-17beta in men with breast cancer. J. Steroid Biochem., 4: 489-501, 1973.
43. Everson, R. B., Li, F. P., Fraumeni, J. F., et al. Familial male breast cancer. Lancet, i: 9-12, 1976.
44. Welsch, C. W., and Meites, J. Prolactin and mammary cancerigenesis. In: R. K Sharma and W. E. Criss (eds.), Endocrine Control in Neoplasia. New York: Raven Press, 1978.
45. Kwa, H. G., Cleton, F., De Jong-Bakker, M., et al. Plasma prolactin and its relationship to risk factors in human breast cancer. Int. J. Cancer, 17: 441-447, 1976.